8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2019 / Interventional study
Researchers used 16S rRNA gene sequencing to assess the effects of 1 week of chlorhexidine antiseptic mouthwash on tongue bacterial communities and resting systolic blood pressure in healthy, normotensive individuals free of oral disease. Tongue cleaning frequency predicted chlorhexidine-induced changes in blood pressure and microbiome composition. Twice-daily chlorhexidine use was associated with a significant increase in systolic blood pressure after 1 week, and recovery led to enrichment of nitrate-reducing bacteria. Furthermore, participants with relatively high levels of bacterial nitrite reductases demonstrated lower resting systolic blood pressure.
Tribble GD, Angelov N, Weltman R, et al. Front Cell Infect Microbiol, 2019. PMID 30881924
2019 / Cluster randomized controlled trial
A cluster randomized trial evaluated an 8-module workplace wellness program led by dietitians across 160 worksites (20 intervention sites with 4,037 employees and 140 control sites with 28,937 employees). After 18 months, intervention participants reported higher rates of engaging in regular exercise (69.8% vs 61.9%; adjusted difference, 8.3 percentage points) and actively managing weight (69.2% vs 54.7%; adjusted difference, 13.6 percentage points). However, there were no significant effects on 27 other self-reported outcomes (including food choices), 10 clinical markers (including cholesterol, blood pressure, and BMI), 38 health spending/utilization metrics, or 3 employment outcomes.
Song Z, Baicker K JAMA, 2019. PMID 30990549
2019 / Two-phase double-blind randomized clinical trial
A two-phase, double-blind randomized clinical trial evaluated the effects of consuming a flavonoid-rich cocoa beverage daily for up to 12 weeks. In the initial study (60 subjects aged 55-70), the flavonoid-rich group showed improvements in glycemia, triglyceridemia, HDL, LDL, the triglyceridemia/HDL index, oxidative markers, the Up and Go test, skeletal muscle index, and quality of life compared to placebo or non-flavonoid cocoa. In the follow-up study (74 subjects aged 65-90), flavonoid treatment significantly improved metabolic, oxidative stress, and inflammatory endpoints, along with positive effects on physical performance, frailty indicators, and quality of life compared with the non-flavonoid beverage.
Munguia L, Rubio-Gayosso I, Ramirez-Sanchez I, et al. J Gerontol A Biol Sci Med Sci, 2019. PMID 31056655
2019 / Randomized controlled trial
A randomized crossover trial evaluated healthy adults completing diets featuring red meat, white meat, or nonmeat protein for 4 weeks each, nested within high-SFA (n = 61) or low-SFA (n = 52) backgrounds. Both red and white meat raised LDL cholesterol and apolipoprotein B compared with nonmeat protein (P < 0.001), mainly by increasing large LDL particles. Primary lipid outcomes showed no significant differences between red and white meat.
Bergeron N, Chiu S, Williams PT, et al. Am J Clin Nutr, 2019. PMID 31161217
2019 / Randomized controlled trial
The Women's Health Initiative Dietary Modification trial randomized 48,835 postmenopausal women to either a low-fat dietary pattern intervention (reducing fat to 20% of energy and increasing vegetables, fruit, and grains) or a usual-diet comparison group. Time-to-outcome analyses showed no significant differences for invasive breast cancer, colorectal cancer, or coronary heart disease (CHD) over an 8.5-year median intervention or longer-term follow-up. However, over a 19.6-year median follow-up, the intervention group had significantly lower hazards for breast cancer followed by death (HR 0.84; 95% CI: 0.74, 0.96) and diabetes requiring insulin (HR 0.87; 95% CI: 0.77, 0.98), along with other benefits related to breast cancer, CHD, and diabetes without adverse effects.
Prentice RL, Aragaki AK, Howard BV, et al. J Nutr, 2019. PMID 31175807
2019 / Randomized crossover trial
Seventeen healthy young subjects consumed a high-fat meal (HFM) along with water, fruit juice, or champagne in a randomized crossover design. Across the whole group, the HFM caused significant hypertriglyceridemia (from 0.77 ± 0.07 to 1.41 ± 0.18 mmol/L, p < 0.001) without overall impairment of FMD. However, in 10 subjects where HFM decreased FMD (from 10.73 ± 0.95 to 8.1 3± 0.86 and 8.07 ± 1.16%; p < 0.05 and p < 0.01 at 2 and 3 hours, respectively), FMD did not decrease when drinking juice or champagne. The authors concluded that fruit juice or champagne might reduce such alterations, though further studies are needed to determine the mechanisms.
Rouyer O, Auger C, Charles AL, et al. J Clin Med, 2019. PMID 31208093
2019 / Randomized double-blind placebo-controlled trial
In a randomized, double-blind trial, patients with type 2 diabetes and CVD received 360 µg/day menaquinone-7 (MK-7, n=35) or placebo (n=33) for 6 months. Target-to-background ratio (TBR) on 18F-NaF PET scans tended to increase in the MK-7 group compared to placebo (0.25; 95% CI: -0.02, 0.51; P = 0.06), but the change was not significant. Log-transformed CT calcification mass did not significantly differ between groups (0.50; 95% CI: -0.23, 1.36; P = 0.18). MK-7 supplementation significantly decreased dp-ucMGP compared with placebo (-205.6 pmol/L; 95% CI: -255.8, -155.3 pmol/L), and no adverse events occurred.
Zwakenberg SR, de Jong PA, Bartstra JW, et al. Am J Clin Nutr, 2019. PMID 31387121
2019 / Randomized crossover trial
In a randomized crossover study, 24 healthy adult males consumed a high-fat breakfast with or without 50 g of freeze-dried mango pulp. At 1 hour post-meal, mango consumption resulted in significantly lower glucose (95.8 ± 4.4 mg/dL vs. 104.8 ± 5.4 mg/dL; P = .002) and higher HDL-C (58.4 ± 2.7 mg/dL vs. 55.2 ± 2.3 mg/dL; P = .01). However, no significant meal × time interactions were observed for triglycerides (P = .88), inflammatory markers (C-reactive protein, P = .17; interleukin-6, P = .30), or antioxidant enzymes (superoxide dismutase, P = .77; glutathione peroxidase, P = .36; catalase, P = .32).
O'Hara C, Ojo B, Emerson SR, et al. Nutr Metab Insights, 2019. PMID 31452602
2019 / Single-arm pre-post intervention study
Researchers evaluated an 8-week group program utilizing an ad-libitum whole-food plant-based dietary pattern in 79 self-referred participants, with 78 completing. Completers achieved an average weight loss of 5.5 ± 3.0 kg (p < 0.0001), with larger percentage losses in those with higher baseline BMI. Systolic blood pressure decreased by 7.1 ± 15.5 mmHg (p = 0.0002), diastolic blood pressure decreased by 7.3 ± 10.9 mmHg (p < 0.0001), total cholesterol decreased by 25.2 ± 24.7 mg/dL (p < 0.0001), and LDL decreased by 15.3 ± 21.1 mg/dL (p < 0.0001). Additionally, 21 participants (26.9%) decreased or stopped at least one chronic medication.
Campbell EK, Fidahusain M, Campbell Ii TM Nutrients, 2019. PMID 31484341
2019 / Prospective intervention study with a matched control group
Researchers compared 27 overweight/obese women with PCOS to 25 matched controls after a 3-day standardized diet, followed by a 3-month oral contraceptive (OC) intervention with dietary advice in the PCOS group. At baseline, the PCOS group showed significantly higher serum levels of TMAO, choline, betaine, and carnitine, with TMAO and choline correlating with total testosterone. Following the 3-month OC therapy and lifestyle intervention, TMAO and its precursors significantly decreased alongside reductions in BMI, total testosterone, and free androgen index.
Eyupoglu ND, Caliskan Guzelce E, Acikgoz A, et al. Clin Endocrinol (Oxf), 2019. PMID 31556132
2019 / Open-label, randomized counterbalanced crossover trial
Seven healthy older overweight volunteers completed four trials consuming a >900 kcal meal with water (control), orange juice, green tea, or red wine, with at least 3 days between visits. At 2 hours post-meal, triglycerides increased substantially and flow-mediated dilatation (FMD) was significantly reduced by ~35%, accompanied by a reduction in plasma nitrite. Co-ingestion of the antioxidant drinks did not attenuate the reduction in FMD and none of the measured outcomes were influenced by the drinks.
Muggeridge DJ, Goszcz K, Treweeke A, et al. Front Physiol, 2019. PMID 31681007
2018 / Acute postprandial intervention study
Researchers measured acute circulating monocyte responses in venous blood samples from 17 participants before and 1, 3, and 5 hours after consuming a high-fat meal providing 85% of their daily fat allowance. The high-fat meal caused increases in oxidized LDL (oxLDL) uptake, adhesion molecule expression, and CD36 expression in both classical (CD14+/16-) and nonclassical (CD14+/16+) monocytes. Nonclassical monocytes responded with larger increases than classical monocytes.
Henning AL, Venable AS, Vingren JL, et al. Cytometry B Clin Cytom, 2018. PMID 27569052
2018 / Randomized controlled pilot trial
Twenty-four obese male veterans were randomized to either a 5:2 intermittent energy-restricted diet or a standard daily energy-restricted diet for 6 months. Mean weight loss was 5.3 ± 3.0 kg (5.5 ± 3.2%) with the 5:2 diet and 5.5 ± 4.3 kg (5.4 ± 4.2%) with standard restriction, with no significant differences between groups for weight or waist reduction. Systolic blood pressure decreased in both groups, but neither regimen significantly shifted diastolic pressure, fasting glucose, or blood lipids.
Conley M, Le Fevre L, Haywood C, et al. Nutr Diet, 2018. PMID 28791787
2018 / Randomized controlled crossover trial
In a randomized controlled crossover trial of 30 participants at risk for cardiovascular diseases, intake of apples with skin (high flavonoid apple) was compared to apple flesh alone (low flavonoid apple). Intake of the high-flavonoid apple resulted in a significant increase in flow-mediated dilation acutely (0.8%, p < 0.001) and after 4 weeks (0.5%, p < 0.001), as well as increased plasma flavonoid metabolites (p < 0.0001). Other measured outcomes, including blood pressure, arterial stiffness, glucose, and lipoproteins, were not altered significantly.
Bondonno NP, Bondonno CP, Blekkenhorst LC, et al. Mol Nutr Food Res, 2018. PMID 29086478
2018 / Randomized crossover trial
During a three-day randomized crossover trial in 21 healthy participants, an isocaloric vegan diet lowered triglycerides, insulin, bile acids, and insulin resistance assessed by HOMA-IR (p < 0.05). It also raised magnesium levels and altered branched-chain amino acid metabolism compared with an omnivorous regimen. Fiber and polyunsaturated fats correlated inversely with triglycerides, insulin, and HOMA-IR.
Draper CF, Vassallo I, Di Cara A, et al. Mol Nutr Food Res, 2018. PMID 29087622
2018 / Randomised crossover study
In a randomised crossover study, 119 older adults (healthy, with COPD, or with stable ischaemic heart disease) completed a 2-hour walk either along a busy commercial street (Oxford Street) or in an urban park (Hyde Park). Walking in Hyde Park increased lung function (FEV1 and FVC) and decreased pulse wave velocity and augmentation index up to 26 hours post-walk across all groups. Conversely, walking on Oxford Street attenuated these beneficial responses, and participants with COPD reported more sputum (OR 3.15, 95% CI 1.39-7.13) and wheeze (OR 4.00, 95% CI 1.52-10.50).
Sinharay R, Gong J, Barratt B, et al. Lancet, 2018. PMID 29221643
2018 / Randomized controlled trial
In an ancillary randomized controlled trial of 53 healthy nonobese adults, 24 months of caloric restriction decreased body weight by 9 ± 0.5 kg, visceral adipose tissue by 0.5 ± 0.01 kg, and blood pressure (systolic -8 ± 3 mmHg; diastolic -6 ± 2 mmHg) compared to ad libitum eating. Total cholesterol fell by 13.6 ± 5.3 mg/dl, LDL-cholesterol decreased by 12.9 ± 4.4 mg/dl, and estimated 10-year cardiovascular risk dropped by 30%. Insulin resistance initially improved during weight loss, but this change was not maintained during weight maintenance.
Most J, Gilmore LA, Smith SR, et al. Am J Physiol Endocrinol Metab, 2018. PMID 29351490
2018 / Randomized trial
Twenty-seven overweight or obese adults were randomized to intermittent energy restriction (IER, n=15) or continuous energy restriction (CER) until achieving 5% weight loss, followed by 7 days of weight stabilization. There was no significant difference in time to 5% weight loss (median 59 d vs 73 d, P=0.246) or body composition changes between groups. Neither diet significantly altered postprandial glycaemia (P=0.266), and insulinaemia was reduced comparatively (P=0.903). However, IER led to a significantly greater relative reduction in postprandial TAG responses (106 to 68 mmol×360 min/l) compared to CER (117 to 130 mmol×360 min/l; P=0.045), and a trend toward a greater reduction in C-peptide (P=0.057).
Antoni R, Johnston KL, Collins AL, et al. Br J Nutr, 2018. PMID 29508693
2018 / Double-blind, crossover, randomized, placebo-controlled trial
In a randomized, double-blind crossover trial, 22 older adults with abdominal obesity underwent a 6-hour oral fat tolerance test after consuming either a supplement (200 mg resveratrol and 100 mg curcumin) or a placebo. Supplementation did not modify postprandial variations in circulating inflammatory markers (CRP, IL-6, IL-8, MCP-1) or adhesion molecules (sE-selectin, sVCAM-1, sICAM-1) compared to placebo (P Treatment×Time > 0.05). However, the supplement significantly reduced the cumulative postprandial response of sVCAM-1 (incremental area under the curve -4643%, P = 0.01), while whole-blood PPARA and NFKB1 gene expressions were unchanged.
Vors C, Couillard C, Paradis ME, et al. J Nutr, 2018. PMID 29546309
2018 / Double-blind, randomized crossover trial
A double-blind, randomized crossover trial evaluated the effects of 16 mg daily of TA-65 (an Astragalus membranaceus extract) versus placebo for 12 weeks with a 3-week washout in 40 patients with metabolic syndrome. Compared to placebo, TA-65 treatment led to significantly higher HDL-C and lower BMI, waist circumference, LDL/HDL ratio, and plasma TNF-alpha (p < 0.05 for all). Changes in HDL-C between periods were negatively correlated with changes in CRP (r = -0.511, p < 0.01), ALT (r = -0.61, p < 0.001), and TNF-alpha (r = -0.550, p < 0.001).
Fernandez ML, Thomas MS, Lemos BS, et al. Curr Pharm Des, 2018. PMID 29546832
2018 / Uncontrolled before-and-after intervention study
Participants in an outpatient cardiovascular clinic consumed a defined plant-based diet excluding all animal products and consisting of raw fruits, vegetables, seeds, and avocado for 4 weeks. Significant reductions were observed in systolic (-16.6 mmHg) and diastolic (-9.1 mmHg) blood pressure (P < 0.0005), serum lipids (P ≤ 0.008), and total medication usage (P < 0.0005). Reductions also occurred in weight (P < 0.0005), waist circumference (P < 0.0005), heart rate (P = 0.018), insulin (P < 0.0005), glycated hemoglobin (P = 0.002), and hs-CRP (P = 0.001).
Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 29575002
2018 / Randomized controlled trial
Twenty men with metabolic syndrome received either autologous or lean vegan-donor fecal transplants. After two weeks, vegan-donor transplants altered microbial community structure toward a vegan profile in some participants. However, the intervention caused no functional changes in TMAO synthesis from choline or carnitine, aortic radiotracer uptake, or cytokine generation from isolated immune cells.
Smits LP, Kootte RS, Levin E, et al. J Am Heart Assoc, 2018. PMID 29581220
2018 / Randomized controlled trial
Forty patients with Hashimoto's thyroiditis aged 22-50 were randomized to receive powdered Nigella sativa or placebo daily for 8 weeks. Treatment with Nigella sativa significantly reduced body weight and body mass index, decreased serum LDL and triglyceride concentrations, and significantly increased HDL cholesterol (P < 0.05), while no such changes were seen in the placebo group. Serum Nesfatin-1 was inversely associated with triglycerides (r = -0.31, P = 0.04).
Farhangi MA, Dehghan P, Tajmiri S Lipids Health Dis, 2018. PMID 29587770
2018 / 2 x 6-week randomized, double-blind, placebo-controlled crossover trial
In a 2 x 6-week randomized, double-blind, placebo-controlled crossover clinical trial, researchers assessed the effects of chronic supplementation with the NAD+ precursor nicotinamide riboside (NR) in healthy middle-aged and older adults. Chronic NR supplementation was well tolerated and effectively stimulated NAD+ metabolism. The results suggest that future clinical trials should further evaluate the potential benefits of NR for reducing blood pressure and arterial stiffness in this population.
Martens CR, Denman BA, Mazzo MR, et al. Nat Commun, 2018. PMID 29599478